What happened
- On October 23, 2026, Scientific Reports published a South Korean national cohort study on proton pump inhibitors, the omeprazole family, and the risk of Parkinson’s disease.
- The authors, from pharmacy schools at four Korean universities, used the National Health Insurance Service national sample cohort of adults aged 40 or older with upper digestive disorders.
- They measured use of these drugs over the previous seven years and analysed it by overall use, cumulative duration and cumulative defined daily dose, with two statistical adjustment methods.
Why it matters
- These antacids are among the frequently used drugs and many people take them for years without review.
- Overall use was not associated with higher Parkinson risk. The signal appears only with long exposures and grows with dose, a pattern the authors say held across several sensitivity analyses.
- It is an observational study: it shows an association and does not prove the drug causes the disease.
The number
2.24 or 1.25. Hazard ratio for people who used the drug for 180 days or more, depending on the method: inverse probability weighting or propensity score matching.
Context
The gap between the two methods is part of the result. With weighting, the estimated risk doubles. With matching, the figure is lower and its confidence interval, from 0.91 to 1.72, includes no effect. With a cumulative dose of 180 daily doses or more, the ratios were 2.20 and 1.32. The authors conclude there is a possible association between high cumulative exposure and Parkinson risk. The link between early factors and neurodegenerative disease is also studied in Alzheimer-like changes in patients with ALS.
What’s next
- The results call for studies that separate the effect of the drug from that of the digestive conditions that lead people to take it.
- For people taking these antacids, the finding is a reason to check with their doctor whether long-term use is still needed, not to stop on their own.
Bottom line
An everyday drug appears linked to Parkinson’s only when used for a long time. Large-scale health data support other findings, such as the circadian subtype of depression in 10,000 patients or smell after covid in vaccinated people. And behaviour in the face of health risks is observed even in macaques that avoid contaminated food.
Sources
- Scientific Reports — Cumulative proton pump inhibitor exposure and risk of Parkinson’s disease: a nationwide cohort study (October 23, 2026)
- Cover image: W.carter, CC0, via Wikimedia Commons
Edited by Rodrigo Cornejo. How we select and verify: who writes these notes.
